Optical Cable Corp Reports Strong Q2 Earnings with Revenue Growth
Optical Cable Corporation's stock surged by 56.10% as it crossed above the 5-day SMA, reflecting strong investor interest following its earnings report.
The company reported a GAAP EPS of $0.12 for Q2, with revenue reaching $22.21 million, marking a year-over-year growth of 26.6%. Additionally, the sales order backlog increased to $13.3 million, up over 27% from January 31, 2026, indicating strong future revenue potential. This positive performance has solidified Optical Cable's position in the optical cable industry and attracted investor attention amid a favorable market outlook.
The significant revenue growth and backlog increase suggest that Optical Cable Corporation is well-positioned for continued success, potentially leading to further stock appreciation as investor confidence grows.
Trade with 70% Backtested Accuracy
Analyst Views on OCC
About OCC
About the author

- Significant Sales Growth: Optical Cable Corp reported a 26.6% year-over-year increase in net sales for Q2 FY2026, reaching $22.2 million, indicating strong market demand and effective sales strategies that are expected to further drive the company's expansion in the data center market.
- Gross Margin Improvement: The gross profit margin improved from 30.4% last year to 34.2%, with gross profit increasing by 42.4% to $7.6 million, demonstrating significant advancements in production and operational efficiency that enhance profitability.
- Increased Order Backlog: The sales order backlog rose to $13.3 million at the end of Q2 2026, up over 27% from $10.4 million in January 2026, reflecting sustained strong market demand that is expected to support future revenue growth.
- Rising SG&A Expenses: Although SG&A expenses increased to $6.3 million primarily due to higher shipping and employee-related costs, the percentage of SG&A to net sales decreased from 32.7% to 28.2%, indicating effective cost control measures by the company.

- Earnings Highlights: Optical Cable Corporation reported a GAAP EPS of $0.12 for Q2, with revenue reaching $22.21 million, reflecting a robust year-over-year growth of 26.6%, which solidifies its position in the optical cable industry.
- Backlog Increase: The company's sales order backlog rose to $13.3 million at the end of Q2 FY2026, up over 27% from $10.4 million as of January 31, 2026, indicating strong future revenue potential.
- Significant Year-over-Year Growth: Compared to $7.3 million as of October 31, 2025, the backlog increased by more than 82%, showcasing a strong market recovery and successful customer acquisition strategies.
- Optimistic Market Outlook: Optical Cable is viewed as a high-risk, high-reward small-cap investment, and with the rising demand for data and power, the market outlook for its future performance appears positive, potentially attracting more investor interest.

- Dycom Industries Surge: Dycom Industries saw its shares soar by up to 35%, reporting a non-GAAP EPS of $4.42, beating estimates by $1.70, with revenue of $1.96 billion exceeding expectations by $290 million, indicating accelerating demand for hyperscale data center construction and fiber deployments, thus boosting market confidence in its future growth.
- Electrical Infrastructure in Demand: As investors focus on AI-related electrical infrastructure, companies like Vicor and Shoals Technologies Group also reached 52-week highs, with Vicor viewed as a leveraged play on AI server power density and Shoals favored for its supply of electrical balance-of-system components for solar projects, reflecting ongoing market interest in electrification and grid-related firms.
- Transportation Stocks Rebound: Transportation stocks such as FedEx, Heartland Express, and Marten Transport also hit 52-week highs, suggesting a growing expectation of recovery in freight demand after years of recession, with FedEx benefiting from ongoing cost-cutting initiatives and expectations of improved industrial activity in the second half of the year.
- Market Trend Shift: This rally indicates a shift in investor focus towards companies linked to infrastructure buildouts, power demand, and physical-world capacity, highlighting a renewed interest in traditional industrial and transportation sectors after years dominated by software and asset-light businesses.
- New Additions: Optical Cable (OCC) and Network-1 Technologies (NTIP) are set to join the FTSE Russell Microcap Index on June 26, which is expected to enhance their market visibility and investment appeal.
- Companies Exiting: Vistance Networks (VISN), Applied Optoelectronics (AAOI), SurgePays (SURG), and Digi International (DGII) will leave the index, potentially leading to decreased liquidity and diminished investor confidence.
- Market Reaction Anticipation: The changes will take effect after US markets close, prompting market participants to closely monitor the impact of these adjustments on the stock prices and portfolios of the affected companies, particularly the negative implications for those exiting the index.
- Industry Dynamics: The reconstitution of the FTSE Russell Microcap Index reflects the dynamic changes within the communications services sector, prompting investors to consider how these shifts may affect overall industry performance and future investment strategies.
- Significant Revenue Growth: Orthocell reported $3.2 million in revenue for the March 2026 quarter, consistent with the previous period, while year-to-date revenue reached $9.4 million, reflecting a 45% increase, indicating strong commercial expansion across multiple markets.
- Accelerating US Market: Sales of Remplir in the US hit $300,000, with $170,000 generated in March alone, suggesting a surge in demand that is expected to enhance the company's market coverage across 16 states, further tapping into its $1.6 billion addressable market.
- Robust Cash Position: At the end of the quarter, Orthocell held $7.8 million in cash and cash equivalents, alongside $40.2 million in term deposits, ensuring a strong financial foundation for ongoing commercial execution, supporting future R&D and marketing efforts.
- Clinical Application Expansion: The company secured approval for Remplir's use across US Department of Defense hospital networks, comprising 221 medical centers, and has already completed the first surgical case, highlighting the effectiveness of its commercial strategy and surgeon engagement activities.







